{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:00:09Z","timestamp":1792004409041,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-024-04791-1","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:03:13Z","timestamp":1709118193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Successful treatment of sino-pulmonary infection & skull base osteomyelitis caused by New Delhi metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in a renal transplant recipient by using an investigational antibiotic cefepime\/zidebactam (WCK 5222)"],"prefix":"10.1007","author":[{"given":"Rajeev","family":"Soman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasika","family":"Sirsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Sunavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"issue":"12","key":"4791_CR1","doi-asserted-by":"publisher","first-page":"e01432","DOI":"10.1128\/AAC.01432-20","volume":"64","author":"JA Karlowsky","year":"2020","unstructured":"Karlowsky JA, Hackel MA, Bouchillon SK, Sahm DF (2020) In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-negative Bacilli not susceptible to Carbapenems. Antimicrob Agents Chemother 64(12):e01432\u2013e01420","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4791_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jinf.2023.04.013","volume":"87","author":"YL Lee","year":"2023","unstructured":"Lee YL, Hsueh PR (2023) Poor in vitro activity of ceftazidime\/avibactam, ceftolozane\/tazobactam, and meropenem\/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018\u20132021. J Infect 87(1):e1\u2013e4","journal-title":"J Infect"},{"key":"4791_CR3","first-page":"546","volume":"140","author":"M Shanthi","year":"2014","unstructured":"Shanthi M, Sekar U, Kamalanathan A, Sekar B (2014) Detection of New Delhi metallo beta lactamase-1 (NDM-1) carbapenemase in Pseudomonas aeruginosa in a single centre in southern India. Indian J Med Res 140:546\u2013550","journal-title":"Indian J Med Res"},{"issue":"5","key":"4791_CR4","doi-asserted-by":"publisher","first-page":"e00517","DOI":"10.1128\/mBio.00517-17","volume":"8","author":"P Jorth","year":"2017","unstructured":"Jorth P, McLean K, Ratjen A, Secor PR, Bautista GE, Ravishankar S et al (2017) Evolved Aztreonam Resistance is multifactorial and can produce hypervirulence in Pseudomonas aeruginosa. mBio 8(5):e00517\u2013e00517","journal-title":"mBio"},{"issue":"6","key":"4791_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/cid\/ciac078","volume":"75","author":"JF Timsit","year":"2022","unstructured":"Timsit JF, Paul M, Shields RK, Echols R, Baba T, Yamano Y et al (2022) Cefiderocol for the Treatment of Infections due to Metallo-B-lactamase-producing pathogens in the CREDIBLE-CR and APEKS-NP phase 3 Randomized studies. Clin Infect Dis 75(6):1081\u20131084","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4791_CR6","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1093\/jac\/dkab280","volume":"76","author":"T Katsube","year":"2021","unstructured":"Katsube T, Nicolau DP, Rodvold KA, Wunderink RG, Echols R, Matsunaga Y et al (2021) Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia. J Antimicrob Chemother 76(11):2902\u20132905","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"4791_CR7","doi-asserted-by":"publisher","first-page":"e01582","DOI":"10.1128\/AAC.01582-20","volume":"64","author":"S Mushtaq","year":"2020","unstructured":"Mushtaq S, Sadouki Z, Vickers A, Livermore DM, Woodford N (2020) Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-negative Bacteria. Antimicrob Agents Chemother 64(12):e01582\u2013e01520","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4791_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/cid\/ciab888","volume":"75","author":"PJ Simner","year":"2022","unstructured":"Simner PJ, Mostafa HH, Bergman Y, Ante M, Tekle T, Adebayo A et al (2022) Progressive Development of Cefiderocol Resistance in Escherichia coli during Therapy is Associated with an increase in blaNDM-5 Copy Number and Gene expression. Clin Infect Dis 75(1):47\u201354","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4791_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/jac\/dkaa391","volume":"76","author":"S Mushtaq","year":"2021","unstructured":"Mushtaq S, Vickers A, Doumith M, Ellington MJ, Woodford N, Livermore DM (2021) Activity of \u03b2-lactam\/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 76(1):160\u2013170","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4791_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/jac\/dkaa036","volume":"75","author":"B Moya","year":"2020","unstructured":"Moya B, Bhagwat S, Cabot G, Bou G, Patel M, Oliver A (2020) Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa. J Antimicrob Chemother 75(6):1474\u20131478","journal-title":"J Antimicrob Chemother"},{"key":"4791_CR11","doi-asserted-by":"publisher","first-page":"e01118","DOI":"10.1128\/mbio.01118-23","volume":"14","author":"AM Hujer","year":"2023","unstructured":"Hujer AM, Marshall SH, Mack AR, Hujer KM, Bakthavatchalam YD, Umarkar K, Palwe SR, Takalkar S, Joshi PR, Shrivastava R, Periasamy H, Bhagwat SS, Patel MV, Veeraraghavan B, Bonomo RA (2023) Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through \u03b2-lactam-enhancer-mechanism-based cefepime\/zidebactam. mBio 14:e01118\u2013e01123","journal-title":"mBio"},{"issue":"1","key":"4791_CR12","first-page":"149","volume":"75","author":"JM Kidd","year":"2020","unstructured":"Kidd JM, Abdelraouf K, Nicolau DP (2020) Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model. J Antimicrob Chemother 75(1):149\u2013155","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4791_CR13","doi-asserted-by":"publisher","first-page":"e0050023","DOI":"10.1128\/aac.00500-23","volume":"67","author":"PK Tirlangi","year":"2023","unstructured":"Tirlangi PK, Wanve BS, Dubbudu RR, Yadav BS, Kumar LS, Gupta A et al (2023) Successful use of Cefepime-Zidebactam (WCK 5222) as a salvage therapy for the treatment of disseminated extensively drug-resistant New Delhi Metallo-\u03b2-Lactamase-producing Pseudomonas aeruginosa infection in an adult patient with Acute T-Cell Leukemia. Antimicrob Agents Chemother 67(8):e0050023","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4791_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12941-023-00606-x","volume":"22","author":"D Dubey","year":"2023","unstructured":"Dubey D, Roy M, Shah TH, Bano N, Kulshrestha V, Mitra S et al (2023) Compassionate use of a novel \u03b2-lactam enhancer-based investigational antibiotic cefepime\/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report. Ann Clin Microbiol Antimicrob 22(1):55","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04791-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:09:56Z","timestamp":1709118596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04791-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":14,"alternative-id":["4791"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04791-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It is a case report. Hence Ethics Committee Approval not required as per our institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed and written consent was taken from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that the patient provided informed consent for publishing his medical details and images as in Fig.\u00a0a f.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}